Clinical trial
Chronic Convection Enhanced Delivery of Topotecan for Recurrent High Grade Gliomas
NCT03154996 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chronic Convection Enhanced Delivery of Topotecan for Recurrent High Grade Gliomas
- Lead sponsor
- Columbia University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 18, 2018
- Completion date
- August 20, 2021
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gliomas